Nick Traggis, is a serial entrepreneur focused on manufacturing and technology development companies. He most recently served as the CEO of Lightdeck Diagnostics, where he negotiated the successful sale of the company to Heska (now part of Antech Diagnostics) in 2023. Before that he worked as the general manager of Precision Photonics; ultimately selling to IDEX Corporation, where he remained as the chief technology officer. He also holds several advisory roles, working with private companies and investment groups, focused on M&A, due diligence, and technology licensing and transfer. Traggis is also an Entrepreneur in Residence at Boulder Ventures (Boulder Ventures Ltd.), and the founder of Ambrosia Biosciences—a small molecule drug development company focused on developing orally available GLP1 and other incretin-based therapeutics.